The effect of interferon-α on the pituitary-adrenal axis

Journal of Interferon and Cytokine Research

Volumn 16, Issue 8, 1996, Pages 619-629

  Menzies, Robert ^a   Phelps, Christopher ^a   Wiranowska, Marzenna ^a   Oliver, Janelle ^a   Chen, Li ^a   Horvath, Elizabeth ^a   Hall, Nicholas ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BOVINE SERUM ALBUMIN; CORTICOSTERONE; CORTICOTROPIN; HUMAN SERUM ALBUMIN; RECOMBINANT ALPHA2A INTERFERON; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; DOSE RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ANIMALIA; BOVINAE;

EID: 0029794810     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.619     Document Type: Article

References (72)

1. BARON, S., TYRING, S.K., FLEISCHMANN, W.R., COPPENHAVER, D.H., NIESEL, D.W., KLIMPEL, G.R., STANTEN, Y., and HUGHS, T.K. (1991). The interferons. Mechanism of action and clinical applications I. JAMA 266, 1375-1383.
2. SMEDLEY, H., KATRAK, M., SIKORA, K., and WHEELER, T. (1983). Neurological effects of recombinant human interferon. Br. Med. J. 286, 262-264.
3. ADAMS, F., QUESADA, J.R., and GUTTERMAN, J.U. (1984). Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA 252, 938-941.
4. PENT, K., and ZBINDEN, G. (1987). Toxicity of interferon and interleukin. Trends Pharmacol. Sci. 8, 100-105.
5. ADAMS, F., FERNANDEZ, F., and MAVLIGIT, G. (1988). Interferon induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities. J. Neurooncol. 6, 355-359.
6. BOCCI, V. (1988). Central nervous system toxicity of interferons and other cytokines. J. Biol. Regul. Homeostatic Agents 2, 107-118.
7. TRIOZZI, P.L., KINNEY, P., and RINEHART, J.J. (1990). Central nervous system toxicity of biological response modifiers. Ann. NY Acad. Sci. 594, 347-354.
8. PRIESTMAN, T.J. (1980). Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease. Lancet 2, 113-118.
9. OKITA, K., and KANEKO, T. (1990). The potential of interferon in malignant disease. Drugs 39, 1-6.
10. BESEDOVSKY, H.O., SORKIN, E., FELIX, D., and HAAS, H. (1977). Hypothalamic changes during the immune process. Eur. J. Immunol. 7, 323-325.
11. HALL, N.R.S., O'GRADY, M.P., and FARAH, L.M. (1991). Thymic hormones and immune function: mediation via neuroendocrine circuits. In: Psychoneuroimmunology. A. Ader, D.L. Felten, and N. Cohen (eds.). New York: Academic Press, pp. 515-528.
12. BESEDOVSKY, H.O., and DEL REY, A. (1991). Physiological implications of the immuno-neuro-endocrine network. In: Psychoneuroimmunology. A. Ader, D.L. Felten, and N. Cohen (eds.) New York: Academic Press, pp. 589-608.
13. ADER, A., FELTEN, D.L., and COHEN, N. (eds.). (1991). Psychoneuroimmunology. New York: Academic Press, pp. 563, 596, 671.
14. BRANCA, A.A. (1986). High-affinity receptors for human interferon in bovine lung and human placenta. J. Interferon Res. 6, 305-311.
15. BRANCA, A.A. (1987). Bovine spleen, a convenient source for purifying a type I interferon receptor. J. Interferon Res. 7, 77-85.
16. LANGER, J.A., and PESTKA, S. (1988). Interferon receptors. Immunol. Today 9, 393-400.
17. CHAMBERS, P.J., SALTIS, J., ALIN, P., WRIGHT, A., LINNANE, A.W., and CHEETHAM, B.F. (1990). Receptors for human interferon α on bovine cells: specificity and tissue distribution. Immunopharm. Immunotox. 12, 513-525.
18. SEN, G.S., and LENGYEL, P. (1992). The interferon system. A birds eye view of its biochemistry. J. Biol. Chem. 267, 5017-5022.
19. PELLIGRINI, S., and SCHINDLER, C. (1993). Early events in signalling by interferons. Trends Biochem. Sci. 18, 338-342.
20. CALVERT, M.U., and GRESSER, I. (1979). Interferon enhances the excitability of cultured neurons. Nature 278, 558.
21. REYES-VASQUEZ, C., PRIETO-GOMEZ, B., GEORGIADES, J.A., and DAFNY, N. (1984). Alpha and gamma interferons' effects on cortical and hippocampal neurons: microiontophoretic application and single recording. Int. J. Neurosci. 25, 113-121.
22. REYES-VASQUEZ, C., WEISBRODT, N., and DAFNY, N. (1984). Does interferon exert its action through opiate receptors? Life Sci. 35, 1015-1021.
23. DAFNY, N. (1983). Interferon modifies morphine withdrawal phenomena in rodents. Neuropharmacology 22, 647-651.
24. DAFNY, N., ZIELINSKI, M., and REYES-VASQUEZ, C. (1983). Alteration of morphine withdrawal to naloxone by interferon. Neuropeptides. 3, 453-463.
25. DAFNY, N., and REYES-VASQUEZ, C. (1985). Three different types of alpha-interferons alter naloxone-induced abstinence in morphine-addicted rats. Immunopharmacology 9, 13-17.
26. HALL, N.R.S., O'GRADY, M.P., and MENZIES, R.A. (1992). Cytokines and the central nervous system: links with mental disorders. In: Stress: Neuroendocrine and Molecular Approaches. R. Kevnatnsky, R. McCarty, and J. Axelrod (eds.). New York: Gordon and Breach Science Publishers.
27. LANGER, J.A., and PESTKA, S. (1985). The structure of interferons. Pharmacol. Ther. 27, 371-400.
28. WIRANOWSKA, M., PROCKOP, L.D., NAIDU, A.K., SAPORTA, S., KORI, S.H., and KULKARNI, A.P. (1994). Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity. Anticancer Res. 14, 1121-1126.
29. STEWART, W.E. II, and SULKIN, S.E. (1966). Interferon production in hamsters experimentally infected with rabies virus. Proc. Soc. Exp. Biol. Med. 123, 650-654.
30. HITCHCOCK, G., and PORTERFIELD, J.S. (1961). The production of interferon in brains of mice infected with an arthropod-borne virus. Virology 13, 363-365.
31. VAINIO, T., GWATKIN, R., and KOPROWSKI, H. (1961). Production of interferon by brains of genetically resistant and susceptible mice infected with West Nile virus. Virology 14, 385-387.
32. LIEBERMAN, A.P., PITHA, P.M., SHIN, H.S., and SHIN, M.L. (1989). Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharides or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86, 6348-6352.
33. SCOTT, G.M., WARD, R.J., WRIGHT, D.J., ROBINSON, J.A., ONWUBALILI, J.K., and GAUCI, C.L. (1983). Effects of cloned interferon alpha2 in normal volunteers: febrile reactions and changes in circulating corticosteroids and trace metals. Antimicrob. Agents Chemother. 23, 589-592.
34. ROOSTH, J., POLLARD, R.B., BROWN, S.L., and MEYER, W.J. III. (1986). Cortisol stimulation by recombinant interferon-alpha2. J. Neuroimmunol. 12, 311-316.
35. MORGANO, A., PUPPO, F., CRISCUOLO, D., LOTTI, G., and INDIVERI, F. (1987). Evening administration of alpha interferon: relationship with the circadian rhythm of Cortisol. Med. Sci. Res. 15, 615-616.
36. D'URSO, R., FALASCHI, P., CANFALONE, G., CARUSI, E., PROIETTI, A., BARNABA, V., and BALSANO, F. (1991). Neuroendocrine effects of recombinant alpha-interferon administration in humans. Prog. Neuroendocrinol. 4, 20-25.
37. MULLER, H., HAMMES, E., HIEMKE, C., and HESS, G. (1991). Interferon-aIpha-2-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinology 54, 499-503.
38. MULLER, H., HIEMKE, C., HAMMES, E., and HESS, G. (1992). Sub-acute effects of interferon-alpha2 on adrenalcorticotrophic hormone, cortisol, growth hormone and prolactin in humans. Psychoendocrinology 5, 459-465.
39. GISSLINGER, H., SVOBODA, T., CLODI, M., GILLY, B., LUDWIG, H., HAVELEC, L., and LUGER, A. (1993). Interferon-alpha stimulates the hypothalmic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57, 489-495.
40. HALL, N.R.S., O'GRADY, M.P., and MENZIES, R.A. (1996). Attenuation of naloxone-precipitated morphine withdrawal by interferon alpha (submitted).
41. SAPHIER, D., WELCH, J.E., and CHULUYAN, H.E. (1993). Alpha-Interferon inhibits adrenocortical secretion via μ1-opioid receptors in the rat. Eur. J. Pharmacol. 236, 183-191.
42. PANCHENKO, L.F., ALYAB'EVA, T.N., PETRICHENKO, O.B., BUMYALIS, V.V., and BALASHOV, A.M. (1988). Opiate receptor binding of μ and δ ligands in rat brain in the presence of Reaferon. Biull. Eksp. Biol. Med. 105, 307-309.
43. MENZIES, R.A., PATEL, R., HALL, N.R.S., O'GRADY, M.P., and RIER, S.E. (1992). Human recombinant interferon inhibits naloxone binding to rat brain membranes. Life Sci. 50, PL227-PL232.
44. KURIYAMA, K., HORI, T., MORI, T., and NAKASHIMA, T. (1990). Actions of interferon-α and interleukin-1β on glucose-responsive neurons in the ventromedial hypothalamus. Brain Res. Bull. 24, 803-810.
45. HARMS, P.G., and OJEDA, S.R. (1974). A rapid and simple procedure for chronic cannulation of the rat jugular vein. J. Appl. Physiol. 36, 391-392.
46. PHELPS, C.P., LENGVARI, I., CARRILLO, A.J., and SAWYER, C.H. (1978). Changes in diurnal fluctuations of plasma thyroid stimulating hormone and corticosterone following anterior hypothalamic deafferentiation in the rat. Brain Res. 141, 283-292.
47. PHELPS, C.P., CHEN, L.T., OLIVER, J., POOLE, L.L., and MENZIES, R.A. (1995). Variable tissue reactions and endocrine responses to a jugular catheter. J. Submicrosc. Cytol. Pathol. 27, 83-89.
48. WALKER, C-D., AKANA, S.F., CASCIO, C.S., and DALLMAN, M.F. (1990). Adrenalectomy in the neonate: adult-like adrenocortical system responses to both removal and replacement of corticosterone. Endocrinology 127, 832-842.
49. WIRANOWSKA-STEWART, M., LIN, L.S., BRAUDE, I.A., and STEWART, W.E. II. (1980). Production, partial purification and characterization of human and murine interferons-type II. Mol. Immunol. 17, 625-633.
50. STEWART, W.E. II. (1979). The Interferon System. Vienna, New York: Springer-Verlag.
51. CHEN, L.T., PHELPS, C.P., OLIVER, J., HORVATH, E., POOLE, L., and MENZIES, R.A. (1994). Hypothalamic-pituitary-adrenal (HPA) axis response to graded increases in endotoxin challenge. J. Endotoxin Res. 31(Suppl. 1) abstract A20.
52. HALL, N.R.S., GELDRED, J.B., OLIVER, J., MENZIES, R.A., RIER, S.E., and O'GRADY, M. (1991). Morphine impairs measures of the immune system in spinal cord-injured rats. Soc. Neurosci. Abstr. 17, 831.
53. SAPHIER, D., ROERIG, S.C., ITO, C., VLASAK, W.R., FARRAR, G.E., BROYLES, J.E., and WELCH, J.E. (1994). Inhibition of neural and neuroendocrine activity by α-interferon: neuroendocrine, electrophysiological and biochemical studies in the rat. Brain Behav. Immun. 8, 37-56.
54. DUNN, A.J. (1992). Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol Exp. Ther. 261, 964-969.
55. DUNN, A.J., and CHULUYAN, H.E. (1992). The role of cyclooxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection. Life Sci. 51, 219-225.
56. HABIF, D.V., LIPTON, R., and CANTELL, K. (1975). Interferon crosses blood-cerebrospinal fluid barrier in monkeys. Proc. Soc. Exp. Biol. Med. 149, 287-289.
57. SMITH, R.A., LANDEL, C., CORNELIUS, C.E., and REVEL, M. (1986). Mapping the action of interferon on primate brain. J. Interferon Res. 6 (Suppl. 1), 140.
58. SMITH, R.A., NORRIS, F., PALMER, D., BERNHARDT, L., and WILLS, R.J., (1985). Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration. Clin. Pharmacol Ther. 37, 85-88.
59. FÄRKKILÄ, M.M., LIVANIANEN, M., ROINE, R., BERGSTRÖM, L., LAAKSONEN, R., NIEMI, M.-J., and CANTRELL, K. (1984). Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta Neurol. Scand. 69, 42-46.
60. WIRANOWSKA, M., WILSON, T.C., THOMPSON, K., and PROCKOP, L.D. (1989). Cerebral interferon entry in mice after osmotic alteration of blood-brain barrier. J. Interferon Res. 9, 353-362.
61. FONTANA, A., WEBER, E., and DAYER, J.M. (1984). Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin treated mice: a step in fever induction. J. Immunol. 133, 1696-1698.
62. DINARELLO, C.A., IKEJIMA, T., WARNER, S.J.C., ORENCOLE, S.F., LONNEMANN, G., CANNON, J.G., and LIBBY, P. (1987). Interleukin 1 induces interleukin 1. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 139, 1902-1910.
63. GUILIAN, D., BAKER, T.J., SHIH, L.C.N., and LACHMAN, L.B. (1986). Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594-604.
64. LARSSON, I., LANDSTROM, L.E., LUNDGREN, E., MIORNER, H., and STRANNEGARD, O. (1978). Interferon production in glia and glioma cell lines. Infect. Immun. 22, 786-789.
65. NAKAMORI, T., MORIMOTO, A., YAMAGUCHI, K., WATANABE, T., LONG, N.C., and MURAKAMI, N. (1993). Organum vasculosum laminae terminalis (OVLT) is a brain site to produce interleukin-1β during fever. Brain Res. 618, 155-159.
66. NAKAMORI, T., MORIMOTO, A., YAMAGUCHI, K., WATANABE, T., and MURAKAMI, N. (1994). Interleukin-1β production in the rabbit brain during endotoxin-induces fever. J. Physiol. 476, 177-186.
67. QUAN, N., SUNDAR, S.K., and WEISS, J.M. (1994). Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49, 125-134.
68. WARNER, S.J.C., AUGER, K.R., and LIBBY, P. (1987). Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J. Immunol. 139, 1911-1917.
69. COCKFIELD, S.M., RAMASSAR, V., NOUJAIM, J., VAN DER MEIDE, P.H., and HALLORAN, P.F. (1993). Regulation of IFNγ expression in vivo. IFNγ up-regulates expression of its mRNA in normal and lipopolysaccaride-stimulated mice. J. Immunol. 150, 717-725.
70. McGILLIS, J.P., HALL, N.R.S., and GOLDSTEIN, A.L. (1988). Thymosin fraction 5 (TF5) stimulates secretion of adrenocorticotropic hormone (ACTH) from cultured rat pituitaries. Life Sci. 42, 2259-2268.
71. MENZIES, R.A., PHELPS, C.P., CHEN, L.T., HALL, N.R.S., OLIVER, J., O'GRADY, M.P., POOLE, L., NICOL, T., and PECKENPAUGH, S. (1993). Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis (HPA). Soc. Neurosci. Abstr. 19, 503.
72. MENZIES, R.A., PHELPS, C.P., CHEN, L.T., HALL, N.R.S., OLIVER, J., POOLE, L., HORVATH, E., and WIRANOWSKA, M. (1994). Neuroimmunomodulatory effects of interferon. Soc. Neurosci. Abstr. 20, 954.